UNC10088 |
|
Katalog-Nr.GC80932
|
UNC10088 is a molecular glue targeting NSD2.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
In Vitro, UNC10088 (0.5 μM, 15 min) drives the SCFFBXO22-dependent polyubiquitination of the NSD2 PWWP1 domain by binding to C326 of FBXO22 to mediate a stable ternary complex, a process reliant on key interacting residues (e.g., FBXO22's E362, K229, E169, and NSD2's F266, E272, K253) wherein mutations disrupt complex stability or degrader positioning and inhibit ubiquitination[1]. UNC10088's (5 μM, 1 h) binding to the FBXO22 FIST domain is exclusively dependent on Cys326, as complex formation is abolished by the C326A mutation and restored by its singular reintroduction into a cysteine-null background[1]. UNC10088 (1 h) exhibits a 2.5-fold reduction in IC50 (from 248 nM to 101 nM) upon the addition of FBXO22, indicating positive cooperative binding with an α-factor of 3.3[1]. UNC10088 significantly increases the melting temperature (Tm) of the FIST domain in wild-type FBXO22; the addition of UNC10088 had almost no effect on the Tm of the C326A mutant[1].
References:
[1]. Robertson KC, et al. Structural basis of NSD2 degradation via targeted recruitment of SCF-FBXO22. bioRxiv [Preprint]. 2025 Aug 30:2025.08.29.673087.
| Cas No. | SDF | ||
| Formula | C35H37N4NaO9S | M.Wt | 712.74 |
| Löslichkeit | Storage | Store at -20°C | |
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.403 mL | 7.0152 mL | 14.0304 mL |
| 5 mM | 280.6 μL | 1.403 mL | 2.8061 mL |
| 10 mM | 140.3 μL | 701.5 μL | 1.403 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)















